PRINCIPAL FINANCIAL GROUP INC
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 1126328
DES MOINES, IA
Position in RIGL
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,032,088
+$716,701 QoQ
Shares Held
51,945
+6.8% QoQ
Ownership
0.278%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 156 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. RIGL ranks #53 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in RIGL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,032,088 | 51,945 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $1,315,387 | 48,646 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $890,992 | 20,803 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $406,732 | 14,357 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $299,566 | 15,994 | Shares | Defined | 2025-08-08 | |
| 2024-03-31 | $91,494 | 61,821 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $208,277 | 143,640 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $131,692 | 121,938 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $128,968 | 99,976 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $151,749 | 114,962 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $198,850 | 132,567 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $53,032 | 44,943 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $52,137 | 46,140 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $151,410 | 50,639 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $131,198 | 49,509 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $251,910 | 69,397 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $287,863 | 66,328 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $255,443 | 74,691 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $272,716 | 77,919 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $523,895 | 218,290 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $269,589 | 147,317 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $73,824 | 47,324 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||